Literature DB >> 21245474

ECG scar quantification correlates with cardiac magnetic resonance scar size and prognostic factors in Chagas' disease.

David G Strauss1, Sávio Cardoso, João A C Lima, Carlos E Rochitte, Katherine C Wu.   

Abstract

OBJECTIVE: To test the hypothesis that 12-lead ECG QRS scoring quantifies myocardial scar and correlates with disease severity in Chagas' heart disease.
DESIGN: Patients underwent 12-lead ECG for QRS scoring and cardiac magnetic resonance with late gadolinium enhancement (CMR-LGE) to assess myocardial scar.
SETTING: University of São Paulo Medical School, São Paulo, Brazil. PATIENTS: 44 Seropositive patients with Chagas' disease without a history of myocardial infarction and at low risk for coronary artery disease. MAIN OUTCOME MEASURES: Correlation between QRS score, CMR-LGE scar size and left ventricular ejection fraction. Relation between QRS score, heart failure (HF) class and history of ventricular tachycardia (VT).
RESULTS: QRS score correlated directly with CMR-LGE scar size (R=0.69, p<0.0001) and inversely with left ventricular ejection fraction (R=-0.54, p=0.0002), which remained significant in the subgroup with conduction defects. Patients with class II or III HF had significantly higher QRS scores than those with class I HF (5.1±3.4 vs 2.1±3.1 QRS points (p=0.002)) and patients with a history of VT had significantly higher QRS scores than those without a history of VT (5.3±3.2% vs 2.6±3.4 QRS points (p=0.02)). A QRS score ≥2 points had particularly good sensitivity and specificity (95% and 83%, respectively) for prediction of large CMR-LGE, and a QRS score ≥7 points had particularly high specificity (92% and 89%, respectively) for predicting significant left ventricular dysfunction and history of VT.
CONCLUSIONS: The wide availability of 12-lead ECG makes it an attractive screening tool and may enhance clinical risk stratification of patients at risk for more severe, symptomatic Chagas' heart disease.

Entities:  

Mesh:

Year:  2011        PMID: 21245474     DOI: 10.1136/hrt.2010.210047

Source DB:  PubMed          Journal:  Heart        ISSN: 1355-6037            Impact factor:   5.994


  25 in total

Review 1.  Chagas heart disease: report on recent developments.

Authors:  Fabiana S Machado; Linda A Jelicks; Louis V Kirchhoff; Jamshid Shirani; Fnu Nagajyothi; Shankar Mukherjee; Randin Nelson; Christina M Coyle; David C Spray; Antonio C Campos de Carvalho; Fangxia Guan; Cibele M Prado; Michael P Lisanti; Louis M Weiss; Susan P Montgomery; Herbert B Tanowitz
Journal:  Cardiol Rev       Date:  2012 Mar-Apr       Impact factor: 2.644

2.  Screening entire health system ECG databases to identify patients at increased risk of death.

Authors:  David G Strauss; Nathan Mewton; Richard L Verrier; Bruce D Nearing; Francis E Marchlinski; Tony Killian; John Moxley; Larisa G Tereshchenko; Katherine C Wu; Raimond Winslow; Christopher Cox; Peter M Spooner; João A C Lima
Journal:  Circ Arrhythm Electrophysiol       Date:  2013-10-12

Review 3.  The year of 2011 in electrocardiology.

Authors:  Shlomo Stern
Journal:  Ann Noninvasive Electrocardiol       Date:  2012-07       Impact factor: 1.468

Review 4.  Diagnosis and Management of Chagas Cardiomyopathy in the United States.

Authors:  Lillian Benck; Evan Kransdorf; Jignesh Patel
Journal:  Curr Cardiol Rep       Date:  2018-10-11       Impact factor: 2.931

5.  Circulating serum markers and QRS scar score in Chagas cardiomyopathy.

Authors:  Eva H Clark; Morgan A Marks; Robert H Gilman; Antonio B Fernandez; Thomas C Crawford; Aaron M Samuels; Alicia I Hidron; Gerson Galdos-Cardenas; Gilberto Silvio Menacho-Mendez; Ricardo W Bozo-Gutierrez; Diana L Martin; Caryn Bern
Journal:  Am J Trop Med Hyg       Date:  2014-11-10       Impact factor: 2.345

6.  A detailed guide for quantification of myocardial scar with the Selvester QRS score in the presence of electrocardiogram confounders.

Authors:  Zak Loring; Sreetharan Chelliah; Ronald H Selvester; Galen Wagner; David G Strauss
Journal:  J Electrocardiol       Date:  2011 Sep-Oct       Impact factor: 1.438

7.  Screening for Cardiac Magnetic Resonance Scar Features by 12-Lead ECG, in Patients with Preserved Ejection Fraction.

Authors:  Nathan Mewton; David G Strauss; Patricia Rizzi; Richard L Verrier; Chia Ying Liu; Larisa G Tereshchenko; Bruce Nearing; Gustavo J Volpe; Francis E Marchlinski; John Moxley; Tony Killian; Katherine C Wu; Peter Spooner; João A C Lima
Journal:  Ann Noninvasive Electrocardiol       Date:  2016-01       Impact factor: 1.468

Review 8.  Developments in the management of Chagas cardiomyopathy.

Authors:  Herbert B Tanowitz; Fabiana S Machado; David C Spray; Joel M Friedman; Oren S Weiss; Jose N Lora; Jyothi Nagajyothi; Diego N Moraes; Nisha Jain Garg; Maria Carmo P Nunes; Antonio Luiz P Ribeiro
Journal:  Expert Rev Cardiovasc Ther       Date:  2015-10-23

9.  Cardiac-oxidized antigens are targets of immune recognition by antibodies and potential molecular determinants in chagas disease pathogenesis.

Authors:  Monisha Dhiman; Maria Paola Zago; Sonia Nunez; Alejandro Amoroso; Hugo Rementeria; Pierre Dousset; Federico Nunez Burgos; Nisha Jain Garg
Journal:  PLoS One       Date:  2012-01-04       Impact factor: 3.240

10.  Inducible nitric oxide synthase in heart tissue and nitric oxide in serum of Trypanosoma cruzi-infected rhesus monkeys: association with heart injury.

Authors:  Cristiano Marcelo Espinola Carvalho; Jaline Coutinho Silverio; Andrea Alice da Silva; Isabela Resende Pereira; Janice Mery Chicarino Coelho; Constança Carvalho Britto; Otacílio Cruz Moreira; Renato Sergio Marchevsky; Sergio Salles Xavier; Ricardo Tostes Gazzinelli; Maria da Glória Bonecini-Almeida; Joseli Lannes-Vieira
Journal:  PLoS Negl Trop Dis       Date:  2012-05-08
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.